Doma Perpetual Capital Management LLC
Filing Date
Global Rank
#3,236
/ 8,588
▲ 148
Top Industry
Drug Manufacturers - Specialty & Generic
18.5%
3Y Alpha vs SPY
-11.1%
Period ended 3 months ago
Filed May 15, 2026 · 33d
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+24.4%
SPY
+55.8%
Annualised alpha
-11.1%
Max drawdown
−15.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
10 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
18.5%
−3.8 pts
Top 5
69.4%
+0.6 pts
Top 10
100.0%
+0.4 pts
HHI
1,212
Diversified−59
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 45.2% | $153,310,482 |
| Consumer Defensive | 19.5% | $66,079,903 |
| Financial Services | 19.2% | $64,970,562 |
| Technology | 8.8% | $29,757,293 |
| Industrials | 7.3% | $24,734,202 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
4 positions
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KNSL | Kinsale Capital Group, Inc. | −6,000 | 50,051 | $17,100,424 | |
| No positions match the current search. | |||||
2 positions ·
$29,757,293 total
· Technology only
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| INTU |
Intuit Inc.
Technology
|
NEW | 44,000 | $19,024,720 | 63.93% | |
| ROP |
Roper Technologies Inc
Technology
|
NEW | 30,330 | $10,732,573 | 36.07% |